Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates.

Autoimmune inflammatory myopathies (AIM) constitute a heterogeneous group of acquired myopathies with endomysial inflammation as a shared feature highlighting a potentially autoimmune inflammatory process amenable to immunotherapies. The disorders ca…

Preview only. Read the full abstract at the source